Nordion is a global health science company that provides market-leading products used for the prevention, diagnosis and treatment of disease. We are a leading provider of sterilization technologies and medical isotopes that benefit the lives of millions of people in more than 40 countries around the world. Learn more >

Latest News

Apr. 1: Nordion Obtains Court Order to Delay its Annual Meeting Date

Mar. 28: Sterigenics Enters into Definitive Agreement to Acquire Nordion

Mar. 4 Nordion Signs Two-Year Strontium-82 Supply Contract with Bracco Diagnostics

Feb. 28: Nordion to Release First Quarter Fiscal 2014 Financial Results

Jan. 9: Nordion Reports Fourth Quarter and Fiscal 2013 Financial Results; Provides Fiscal 2014 Outlook
· Earnings Call/Webcast

Dec. 10: Nordion to Release Fourth Quarter and Fiscal 2013 Financial Results

Nov. 4: Nordion Shares How the Science of Irradiation is Solving Today's Unique Global Product Challenges

Oct. 16: Collaboration with Adesto Technologies and Nordion Confirms Gamma Irradiation Tolerance of CBRAM® Non-Volatile Memory

Sept. 24: Nordion and BioAxone BioSciences Reach an Agreement to Settle Claims

Sep. 5: Nordion Reports Third Quarter Fiscal 2013 Financial Results
· Q3 Report/MD&A
· Earnings Call/Webcast (Slides / Transcript)

More news >

Upcoming Events

Mar. 28: Sterigenics Enters into Definitive Agreement to Acquire Nordion - Analyst Conference Call

Dec. 19: Nordion to Release Fourth Quarter and Fiscal 2013 Financial Result on January 9, 2014

Sep. 10 - 11: Latex & Synthetic Polymer Dispersions 2013

Nov. 4 - 8: IMRP 2013 – 17th International Meeting on Radiation Processing

More events >

Stock Quote

Apr 17 3:59 p.m. ET
delayed 20 minutes

TSX:NDN

PRICE: $12.58
CHANGE:0.16
VOLUME:34,277

NYSE:NDZ

PRICE: $11.43
CHANGE:0.14
VOLUME:386,797

More >

Follow Nordion

Find Nordion on Facebook   Find Nordion on Twitter   Find Nordion on YouTube   Find Nordion on LinkedIn   Subscribe to e-mail alerts   Subscribe to news via RSS   Bookmark and Share   
footer